Study details
Enrolling now
Adjuvant Curcumin Trial
yair lotan
NCT IDNCT02064673ClinicalTrials.gov data as of Apr 2026
Phase
Phase 3
Target enrollment
608
Study length
about 15 years
Ages
30–80
Sex
Male only
Locations
1 site in TX
What this study is about
Researchers are testing whether adding curcumin to standard treatment improves the time before prostate cancer returns after surgery. The trial will involve men who have had radical prostatectomy and are being treated with a treatment.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Curcumin
- 2.Take placebo
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Oral
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Drug classes
dietary supplement
Drug routes
oral (Oral Capsule)
Body systems
Oncology